Sign Out
Posology: The single dose is 1 ml per kg body weight.
Administration should be initiated on the day of transplantation. In case of bone marrow transplantation an initiation of prophylaxis up to 10 days before transplantation can also be envisaged, particularly in CMV sero-positive patients. A total of at least 6 single doses at 2 to 3 weeks' intervals should be given.
Paediatric population: The posology in children and adolescents (0-18 years) is not different to that of adults as the posology for each indication is given by body weight and adjusted to the clinical outcome of the above mentioned conditions.
Hepatic impairment: No evidence is available to require a dose adjustment.
Renal impairment: No dose adjustment unless clinically warranted, see Precautions.
Elderly: No dose adjustment unless clinically warranted, see Precautions.
Method of administration: Intravenous use.
Megalotect CP should be infused intravenously at an initial rate of 0.08 ml/kg BW/hr for 10 minutes. See Precautions. In case of adverse reaction, either the rate of administration must be reduced or the infusion stopped. If well tolerated, the rate of administration may gradually be increased to a maximum of 0.8 ml/kg BW/hr for the remainder of the infusion.
Continue with Google